Evidence map›Paper›PMID 41035129›Full record

ArticleActa ophthalmologica2026

Refining laissez-faire treatment of periocular tumour defects by exploring the impact of defect localization and geometry on the healing process.

Jens Nääv Ottosson, Adrianna Opalko, Johanna Berggren, Kajsa Tenland, John Albinsson, Aboma Merdasa, Elin Bohman, Malin Malmsjö

Abstract read
In one paragraph

Article in Acta ophthalmologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jens Nääv OttossonDepartment of Clinical Sciences Lund, Ophthalmology, Skåne University Hospital, Lund University, Lund, Sweden.
Adrianna OpalkoDepartment of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden.
Johanna BerggrenDepartment of Clinical Sciences Lund, Ophthalmology, Skåne University Hospital, Lund University, Lund, Sweden.
Kajsa TenlandDepartment of Clinical Sciences Lund, Ophthalmology, Skåne University Hospital, Lund University, Lund, Sweden.
John AlbinssonDepartment of Clinical Sciences Lund, Ophthalmology, Skåne University Hospital, Lund University, Lund, Sweden.
Aboma MerdasaDepartment of Clinical Sciences Lund, Ophthalmology, Skåne University Hospital, Lund University, Lund, Sweden.
Elin BohmanDepartment of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden.
Malin MalmsjöDepartment of Clinical Sciences Lund, Ophthalmology, Skåne University Hospital, Lund University, Lund, Sweden.ORCID https://orcid.org/0000-0001-9849-9599

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLarge lower eyelid defects resulting from tumour removal are frequently reconstructed using a tarsoconjunctival flap from the upper eyelid together with an overlying free skin graft, the so-called Hughes procedure. One disadvantage of this technique is that the tarsoconjunctival flap occludes the eye during the revascularization of the graft, which is particularly troublesome for patients with poor vision in the other eye. Another alternative method for reconstructing large lower eyelid defects is the use of a free bilamellar eyelid graft with the advantage that it is a single-stage procedure and that the vision is not occluded during the healing process. However, both these methods require extensive surgery, which is time-consuming and might be too much effort for the frail and elderly. In these specific cases, where one wishes to avoid extensive surgery, laissez-faire treatment, so-called self-healing, might be an alternative.

methods46 patients undergoing laissez-faire treatment for periocular tumour defects were included. Surgical defects were in the medial canthal area (n = 10) and the lower eyelid (n = 28), with the latter classified as proportional (n = 21) or disproportional (n = 7) based on the anterior to posterior lamellae ratio. Cases requiring repeated surgical excisions due to tumour-positive margins (n = 8) were analysed separately. Wound contraction was assessed through serial photography after 1 week, 3 weeks, 6-8 weeks, and 5 months to 2 years. Defect size was standardized using corneal area measurements.

resultsProportional lower eyelid defects exhibited predictable healing, with rapid wound contraction the first 6-8 weeks and minimal complications. Disproportional defects showed uneven healing, resulting in ectropion or significant tissue loss in 6 of 7 cases. Medial canthal defects generally healed well, but larger defects (>50% of corneal area) took longer to contract and were associated with traction-related complications in isolated cases. Repeated surgical excisions were associated with a higher prevalence of complications, including ectropion, entropion, and residual defects.

conclusionsDefect geometry is crucial in the healing process and clinical outcomes of periocular defects treated with laissez-faire. Medial canthal defects and proportional lower eyelid defects heal more reliably, while disproportional and large medial canthal defects, as well as cases requiring repeated surgical excisions, pose a higher risk of complications. These findings emphasize the importance of careful patient selection and defect analysis to optimize outcomes.

Indexed as

BlepharoplastyEyelid NeoplasmsEyelidsPlastic Surgery ProceduresSurgical FlapsWound HealingAgedAged, 80 and overFemaleFollow-Up StudiesHumansMaleMiddle AgedRetrospective Studieseyelidlaissez‐fairetumourswound healing

Identifiers

PMID41035129
PMCPMC13166378

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.